Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Jäger

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Wiener Klinische Wochenschrift|September 19, 2003
Innovative strategies in lymphoma therapyUlrich Jäger
Blood|September 13, 2021
How I manage autoimmune cytopenias in patients with lymphoid cancerEdit Porpaczy, Ulrich Jäger
Blood|June 16, 2010
How I treat autoimmune hemolytic anemias in adultsKlaus Lechner, Ulrich Jäger
Hemasphere|November 15, 2019
CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and HopeGeorg Hopfinger, Ulrich Jäger, Nina Worel
Leukemia & Lymphoma|July 20, 2011
Acquired immune-mediated thrombophilia in lymphoproliferative disordersKlaus Lechner, Ingrid Simonitsch, Johanna Haselböck, et al.
Hemasphere|November 15, 2019
Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in EuropeJochen Buechner, Marie José Kersten, Miriam Fuchs, et al.
Annals of Hematology|April 3, 2004
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenumMartha Hoffmann, Andreas Chott, Andreas Püspök, et al.
European Journal of Haematology|November 19, 2014
Interleukin-10 inhibits autonomous myelopoiesis in patients with myelofibrosisKlaus Geissler, Eva Jäger, Leopold Öhler, et al.
Orphanet Journal of Rare Diseases|October 8, 2016
Combined integrated protocol/basket trial design for a first-in-human trialUlla Derhaschnig, Jim Gilbert, Ulrich Jäger, et al.
Haematologica|February 14, 2007
CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantationSylvain Choquet, Ralf Trappe, Veronique Leblond, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Wiener Klinische Wochenschrift|September 19, 2003
Innovative strategies in lymphoma therapyUlrich Jäger
Blood|September 13, 2021
How I manage autoimmune cytopenias in patients with lymphoid cancerEdit Porpaczy, Ulrich Jäger
Blood|June 16, 2010
How I treat autoimmune hemolytic anemias in adultsKlaus Lechner, Ulrich Jäger
Hemasphere|November 15, 2019
CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and HopeGeorg Hopfinger, Ulrich Jäger, Nina Worel
Leukemia & Lymphoma|July 20, 2011
Acquired immune-mediated thrombophilia in lymphoproliferative disordersKlaus Lechner, Ingrid Simonitsch, Johanna Haselböck, et al.
Hemasphere|November 15, 2019
Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in EuropeJochen Buechner, Marie José Kersten, Miriam Fuchs, et al.
Annals of Hematology|April 3, 2004
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenumMartha Hoffmann, Andreas Chott, Andreas Püspök, et al.
European Journal of Haematology|November 19, 2014
Interleukin-10 inhibits autonomous myelopoiesis in patients with myelofibrosisKlaus Geissler, Eva Jäger, Leopold Öhler, et al.
Orphanet Journal of Rare Diseases|October 8, 2016
Combined integrated protocol/basket trial design for a first-in-human trialUlla Derhaschnig, Jim Gilbert, Ulrich Jäger, et al.
Haematologica|February 14, 2007
CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantationSylvain Choquet, Ralf Trappe, Veronique Leblond, et al.
Pageof 15